Human IL-2 Antibody Summary
Ala21-Thr153
Accession # NP_000577
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Cell Proliferation Induced by IL‑2 and Neutralization by Human IL‑2 Antibody. Recombinant Human IL-2 (Catalog # 202-IL) stimulates proliferation in the CTLL-2 mouse cytotoxic T cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IL-2 (2 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IL-2 Monoclonal Antibody (Catalog # MAB202). The ND50 is typically 0.015-0.03 µg/mL.
IL‑2 in Human PBMCs. IL-2 was detected in immersion fixed human peripheral blood mononuclear cells (PBMCs) treated with calcium ionomycin and PMA using Mouse Anti-Human IL-2 Monoclonal Antibody (Catalog # MAB202) at 8 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-2
Interleukin 2 (IL-2) is a cytokine that stimulates the growth and differentiation of B cells, T cells, NK cells, and monocyte/macrophages. It functions through the heterotrimeric IL-2 receptor comprising alpha, beta, and gamma chains.
Product Datasheets
Citations for Human IL-2 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
17
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
CXCL13-producing CD4+ T cells accumulate in early phase of tertiary lymphoid structures in ovarian cancer
Authors: M Ukita, J Hamanishi, H Yoshitomi, K Yamanoi, S Takamatsu, A Ueda, H Suzuki, Y Hosoe, Y Furutake, M Taki, K Abiko, K Yamaguchi, H Nakai, T Baba, N Matsumura, A Yoshizawa, H Ueno, M Mandai
JCI Insight, 2022-06-22;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Immunogenicity profile in African green monkeys of a vaccine candidate based on a mutated form of human Interleukin-15
Authors: Y Rodríguez-, LG Batista-Ro, A Llopiz-Arz, P Puente-Pér, R Martínez-C, J Castro-Vel, A Santos-Sav
BMC immunology, 2021-12-18;22(1):79.
Species: Mouse
Sample Types: Whole Cells
Applications: Neutralization -
An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer
Authors: D Sahin, N Arenas-Ram, M Rath, U Karakus, M Hümbelin, M van Gogh, L Borsig, O Boyman
Nature Communications, 2020-12-22;11(1):6440.
Species: Human, Mouse
Sample Types: Recombinant Protein, Serum
Applications: ELISA Detection -
Suppressor of cytokine signaling 3 is crucial for interleukin-7 receptor re-expression after T-cell activation and interleukin-7 dependent proliferation
Authors: A Güler, ML Venegas, E Adankwah, E Mayatepek, N Nausch, M Jacobsen
Eur. J. Immunol., 2019-11-14;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Effects of pepsin and pepstatin on reflux tonsil hypertrophy in vitro
Authors: JH Kim, SJ Jang, JW Yun, MH Jung, SH Woo
PLoS ONE, 2018-11-08;13(11):e0207090.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Blocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells
Authors: T Carmenate, Y Ortíz, M Enamorado, K García-Mar, J Avellanet, E Moreno, L Graça, K León
J. Immunol., 2018-04-04;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
IL-23 and IL-1? Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation
Authors: S Revu, J Wu, M Henkel, N Rittenhous, A Menk, GM Delgoffe, AC Poholek, MJ McGeachy
Cell Rep, 2018-03-06;22(10):2642-2653.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling
Sci Rep, 2016-09-02;6(0):32320.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry, Neutralization -
Activin A programs the differentiation of human TFH cells
Nat Immunol, 2016-07-04;17(8):976-84.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum.
Authors: Nata T, Basheer A, Cocchi F, van Besien R, Massoud R, Jacobson S, Azimi N, Tagaya Y
J Biol Chem, 2015-07-16;290(37):22338-51.
Species: Human
Sample Types: Protein
Applications: Neutralization -
Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells.
Authors: Kim, Dae Won, Zloza, Andrew, Broucek, Joseph, Schenkel, Jason M, Ruby, Carl, Samaha, Georges, Kaufman, Howard L
J Transl Med, 2014-05-06;12(0):113.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation.
Blood, 2012-05-10;119(26):6268-77.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive.
Authors: Hutnick NA, Carnathan D, Demers K, Makedonas G, Ertl HC, Betts MR
Vaccine, 2010-02-23;28(8):1932-41.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue.
Authors: Withers DR, Fiorini C, Fischer RT, Ettinger R, Lipsky PE, Grammer AC
Blood, 2007-02-13;109(11):4856-64.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
Authors: Karenko L, Hahtola S, Paivinen S, Karhu R, Syrja S, Kahkonen M, Nedoszytko B, Kytölä S, Zhou Y, Blazevic V, Pesonen M, Nevala H, Nupponen N, Sihto H, Krebs I, Poustka A, Roszkiewicz J, Saksela K, Peterson P, Visakorpi T, Ranki A
Cancer Res., 2005-09-15;65(18):8101-10.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry, ICC -
Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells.
Authors: Sen Y, Chunsong H, Baojun H, Linjie Z, Qun L, San J, Qiuping Z, Junyan L, Zhang X, Jinquan T
Immunology, 2004-06-01;112(2):274-89.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Reprogramming of IL-10 activity and signaling by IFN-gamma.
Authors: Herrero C, Hu X, Li WP, Samuels S, Sharif MN, Kotenko S, Ivashkiv LB
J. Immunol., 2003-11-15;171(10):5034-41.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization
FAQs
-
Can Catalog # MAB202 (anti-Human IL-2 antibody) be used for neutralization of mouse IL-2?
No. MAB202 is not cross-reactive to mouse IL-2 and so cannot be used for neutralization of mouse IL-2.
Reviews for Human IL-2 Antibody
Average Rating: 4.5 (Based on 2 Reviews)
Have you used Human IL-2 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: